Volume 10 Issue 3
May  2019
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2019  >  10(3): 267-277
Branch of Organ Transplantation of Chinese Medical Association. Clinical technical operation specification for pathology of organ transplantation (2019 edition): liver transplantation[J]. ORGAN TRANSPLANTATION, 2019, 10(3): 267-277. doi: 10.3969/j.issn.1674-7445.2019.03.008
Citation: Branch of Organ Transplantation of Chinese Medical Association. Clinical technical operation specification for pathology of organ transplantation (2019 edition): liver transplantation[J]. ORGAN TRANSPLANTATION, 2019, 10(3): 267-277. doi: 10.3969/j.issn.1674-7445.2019.03.008
shu

Clinical technical operation specification for pathology of organ transplantation (2019 edition): liver transplantation

doi: 10.3969/j.issn.1674-7445.2019.03.008
  • Received Date: 2019-02-06
    Available Online: 2021-01-19
  • Publish Date: 2019-05-15
    Abstract
    • FullText(HTML)
  • loading
    • References(38)
  • [1]
    LUCEY MR, TERRAULT N, OJO L, et al. Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation[J]. Liver Transpl, 2013, 19(1):3-26. DOI: 10.1002/lt.23566.
    [2]
    OP DEN DRIES S, WESTERKAMP AC, KARIMIAN N, et al. Injury to peribiliary glands and vascular plexus before liver transplantation predicts formation of non-anastomotic biliary strictures[J]. J Hepatol, 2014, 60(6):1172-1179. DOI: 10.1016/j.jhep.2014.02.010.
    [3]
    顾怡瑾, 冼志红, 俞花, 等.肝移植穿刺活检组织快速石蜡制片[J].临床与实验病理学杂志, 2010, 26(6):761-762. DOI: 10.3969/j.issn.1001-7399.2010.06.034.

    GU YJ, XIAN ZH, YU H, et al. Rapid paraffin section for puncture biopsy tissue of liver transplantation[J]. Chin J Clin Exp Path, 2010, 26(6):761-762. DOI: 10.3969/j.issn.1001-7399.2010.06.034.
    [4]
    丛文铭.肝脏移植临床病理学[M].北京:军事医学科学出版社, 2011.
    [5]
    丛文铭, 步宏, 陈杰, 等.原发性肝癌规范化病理诊断指南(2015版)[J].临床与实验病理学杂志, 2015, 31(3):241-246.DOI: 10.13315/j.cnki.cjcep.2015.03.001.

    CONG WM, BU H, CHEN J, et al. Guideline for standardized pathological diagnosis of primary hepatic carcinoma(2015 edition)[J]. Chin J Clin Exp Path, 2015, 31(3):241-246.DOI: 10.13315/j.cnki.cjcep.2015.03.001.
    [6]
    王政禄, 郑虹.器官移植生物样本库建设实践指南[J].中华器官移植杂志, 2019, 40(1):1-9. DOI: 10.3760/cma.j.issn.0254-1785.2019.01.002.

    WANG ZL, ZHENG H. Practical guide to the construction of biological sample bank for organ transplantation[J]. Chin J Organ Transplant, 2019, 40(1):1-9. DOI: 10.3760/cma.j.issn.0254-1785.2019.01.002.
    [7]
    SPITZER AL, LAO OB, DICK AA, et al. The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment[J]. Liver Transpl, 2010, 16(7):874-884. DOI: 10.1002/lt.22085.
    [8]
    DUTKOWSKI P, SCHLEGEL A, SLANKAMENAC K, et al. The use of fatty liver grafts in modern allocation systems: risk assessment by the balance of risk (BAR) score[J]. Ann Surg, 2012, 256(5):861-869. DOI: 10.1097/SLA.0b013e318272dea2.
    [9]
    MORRISSEY PE, MONACO AP. Donation after circulatory death: current practices, ongoing challenges, and potential improvements[J]. Transplantation, 2014, 97(3):258-264. DOI: 10.1097/01.TP.0000437178.48174.db.
    [10]
    MILLER CM, DURAND F, HEIMBACH JK, et al. The International Liver Transplant Society guideline on living liver donation[J]. Transplantation, 2016, 100(6):1238-1243. DOI: 10.1097/TP.0000000000001247.
    [11]
    CURSIO R, GUGENHEIM J. Ischemia-reperfusion injury and ischemic-type biliary lesions following liver transplantation[J]. J Transplant, 2012:164329. DOI: 10.1155/2012/164329.
    [12]
    DEMETRIS AJ, KELLY DM, EGHTESAD B, et al. Pathophysiologic observations and histopathologic recognitio of the portal hyperperfusion or small-for-size syndrome[J]. Am J Surg Pathol, 2006, 30(8):986-993. doi: 10.1097/00000478-200608000-00009
    [13]
    董辉, 丛文铭.肝移植后抗体介导性排斥反应的进展[J].中华器官移植杂志, 2014, 35(8):509-511.DOI: 10.3760/cma.j.issn.0254-1785.2014.08.016.

    DONG H, CONG WM. Advances in antibody-mediated rejection after liver transplantation[J]. Chin J Organ Transplant, 2014, 35(8):509-511.DOI:10.3760/cma.j.issn.0254-1785.2014. 08.016.
    [14]
    HÜBSCHER SG. Antibody-mediated rejection in the liver allograft[J]. Curr Opin Organ Transplant, 2012, 17(3):280-286. DOI: 10.1097/MOT.0b013e328353584c.
    [15]
    O' LEARY JG, MICHELLE SHILLER S, BELLAMY C, et al. Acute liver allograft antibody-mediated rejection: an inter-institutional study of significant histopathological features[J]. Liver Transpl, 2014, 20(10):1244-1255. DOI: 10.1002/lt.23948.
    [16]
    KIM PT, DEMETRIS AJ, O' LEARY JG. Prevention and treatment of liver allograft antibody-mediated rejection and the role of the ' two-hit hypothesis' [J]. Curr Opin Organ Transplant, 2016, 21(2):209-218. DOI: 10.1097/MOT.0000000000000275.
    [17]
    O' LEARY JG, CAI J, FREEMAN R, et al. Proposed diagnostic criteria for chronic antibody-mediated rejection in liver allografts[J]. Am J Transplant, 2016, 16(2): 603-614. DOI: 10.1111/ajt.13476.
    [18]
    DEMETRIS AJ, BELLAMY C, HÜBSCHER SG, et al. 2016 comprehensive update of the Banff Working Group on liver allograft pathology: introduction of antibody-mediated rejection[J]. Am J Transplant, 2016, 16(10):2816-2835. DOI: 10.1111/ajt.13909.
    [19]
    KOZLOWSKI T, ANDREONI K, SCHMITZ J, et al. Sinusoidal C4d deposits in liver allografts indicate an antibody-mediated response: diagnostic considerations in the evaluation of liver allografts[J]. Liver Transpl, 2012, 18(6):641-658. DOI: 10.1002/lt.23403.
    [20]
    LUNZ J, RUPPERT KM, CAJAIBA MM, et al. Re-examination of the lymphocytotoxic crossmatch in liver transplantation: can C4d stains help in monitoring?[J]. Am J Transplant, 2012, 12(1):171-182. DOI: 10.1111/j.1600-6143.2011.03786.x.
    [21]
    丛文铭, 陆新元, 董辉, 等.肝移植术后急性排异的病理类型与转归:附1120例次肝穿刺分析[J].临床与实验病理学杂志, 2011, 27(2):117-120.DOI: 10.3969/j.issn.1001-7399.2011.02.002.

    CONG WM, LU XY, DONG H, et al. Clinicopathological classifications and significance of acute rejection after liver transplantation: an analysis on 1120 liver biopsies[J].Chin J Clin Exp Path, 2011, 27(2):117-120. DOI: 10.3969/j.issn.1001-7399.2011.02.002.
    [22]
    ALI S, ORMSBY A, SHAH V, et al. Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection[J]. Transpl Immunol, 2012, 26(1):62-69. DOI: 10.1016/j.trim.2011.08.005.
    [23]
    CASTILLO-RAMA M, SEBAGH M, SASATOMI E, et al. " Plasma cell hepatitis" in liver allografts: identification and characterization of an IgG4-rich cohort[J]. Am J Transplant, 2013, 13(11): 2966-2977. DOI: 10.1111/ajt.12413.
    [24]
    王政禄, 胡占东, 蔡文娟, 等.儿童肝移植术后常见并发症的临床病理特点分析[J].中华器官移植杂志, 2018, 39(9):527-533.DOI: 10.3760/cma.j.issn.0254-1785.2018.09.004.

    WANG ZL, HU ZD, CAI WJ, et al. Clinicopathological features analysis of common complications in pediatric liver transplantation[J]. Chin J Organ Transplant, 2018, 39(9):527-533.DOI: 10.3760/cma.j.issn.0254-1785.2018.09.004.
    [25]
    ABRAHAM SC, FREESE DK, ISHITANI MB, et al. Significance of central perivenulitis in pediatric liver transplantation[J]. Am J Surg Pathol, 2008, 32(10):1479-1488. DOI: 10.1097/PAS.0b013e31817a8e96.
    [26]
    任美欣, 孟庆华.肝移植术后药物性肝损伤研究进展[J/CD].肝癌电子杂志, 2016, 3(2):8-10.DOI: 10.3969/j.issn.2095-7815.2016.02.005.

    REN MX, MENG QH. Drug induced liver injury after liver transplantation[/CD]. Electr J Liver Tumor, 2016, 3(2): 8-10. DOI: 10.3969/j.issn.2095-7815.2016.02.005.
    [27]
    中华医学会肝病学分会药物性肝病学组.药物性肝损伤诊治指南[J].中华肝脏病杂志, 2015, 23(11):810-820.DOI: 10.3760/cma.j.issn.1007-3418.2015.11.004.

    Pharmacological Hepatology Group of Branch of Hepatology of Chinese Medical Association. Diagnosis and treatment guideline on drug-induced liver injury[J]. Chin J Hepatol, 2015, 23(11):810-820. DOI:10.3760/cma.j.issn.1007-3418.2015. 11.004.
    [28]
    SEMBERA S, LAMMERT C, TALWALKAR JA, et al. Frequency, clinical presentation, and outcomes of drug-induced liver injury after liver transplantation[J]. Liver Transpl, 2012, 18(7):803-810. DOI: 10.1002/lt.23424.
    [29]
    ZHENGLU W, HUI L, SHUYING ZH, et al. A clinical-pathological analysis of drug-induced hepatic injury after liver transplantation[J]. Transplant Proc, 2007, 39(10):3287-3291. doi: 10.1016/j.transproceed.2007.08.096
    [30]
    KERKAR N, YANNI G. ' De novo' and ' recurrent' autoimmune hepatitis after liver transplantation: a comprehensive review[J]. J Autoimmun, 2016, 66:17-24. DOI: 10.1016/j.jaut.2015.08.017.
    [31]
    GASTACA M. Biliary complications after orthotopic liver transplantation: a review of incidence and risk factors[J]. Transplant Proc, 2012, 44(6):1545-1549. DOI: 10.1016/j.transproceed.2012.05.008.
    [32]
    中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南[J].中华肝脏病杂志, 2005, 13(12):881-891.DOI: 10.3760/j.issn.1007-3418.2005.12.001.

    Branch of Hepatology of Chinese Medical Association, Branch of Infectious Diseases of Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B[J]. Chin J Hepatol, 2005, 13(12):881-891. DOI: 10.3760/j.issn.1007-3418.2005.12.001.
    [33]
    KARIMIAN N, WESTERKAMP AC, PORTE RJ. Biliary complications after orthotopic liver transplantation[J]. Curr Opin Organ Transplant, 2014, 19(3):209-216. DOI: 10.1097/MOT.0000000000000082.
    [34]
    SEBAGH M, CASTILLO-RAMA M, AZOULAY D, et al. Histologic findings predictive of a diagnosis of de novo autoimmune hepatitis after liver transplantation in adults[J]. Transplantation, 2013, 96(7):670-678. DOI: 10.1097/TP.0b013e31829eda7f.
    [35]
    MIYAGAWA-HAYASHINO A, HAGA H, EGAWA H, et al. Idiopathic post-transplantation hepatitis following living donor liver transplantation, and significance of autoantibody titre for outcome[J]. Transpl Int, 2009, 22(3):303-312. DOI: 10.1111/j.1432-2277.2008.00803.x.
    [36]
    SANADA Y, MATSUMOTO K, URAHASHI T, et al. Protocol liver biopsy is the only examination that can detect mid-term graft fibrosis after pediatric liver transplantation[J]. World J Gastroenterol, 2014, 20(21):6638-6650. DOI: 10.3748/wjg.v20.i21.6638.
    [37]
    SWERDLOW SH, CAMPO E, PILERI SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms[J]. Blood, 2016, 127(20):2375-2390. DOI: 10.1182/blood-2016-01-643569.
    [38]
    RUIZ P.移植病理学[M].沈中阳, 陈新国, 译.北京: 人民军医出版社, 2015.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(10)  / Tables(2)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (321) PDF downloads(110) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return